Albertsons Companies (ACI) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
22 Jun, 2026Executive summary
Annual meeting scheduled for August 6, 2026, to be held virtually, with voting on key proposals and director elections.
CEO reflects on a year of disciplined execution, digital transformation, and productivity initiatives, positioning the company for long-term growth.
Strategic priorities include optimizing the store footprint, enhancing customer-centric experiences, and maintaining balanced value through pricing, loyalty, and automation.
Community engagement and sustainability efforts resulted in $497 million in food and financial support, enabling over 207 million meals in 2025.
Voting matters and shareholder proposals
Election of 10 directors for a one-year term.
Ratification of Deloitte & Touche LLP as independent auditor for fiscal year ending February 27, 2027.
Advisory vote on executive compensation (say-on-pay).
Management proposals to amend the Certificate of Incorporation: eliminate supermajority voting and extend officer exculpation.
Stockholder proposal requesting a report on human rights policy and due diligence, with Board recommending a vote against.
Board of directors and corporate governance
Board comprises 10 nominees, 70% independent, with diverse skills in finance, technology, retail, and risk management.
Separate CEO and independent Chair structure; annual board and committee evaluations; robust stock ownership guidelines.
Cerberus Capital Management retains director nomination rights based on ownership.
Five standing committees: Audit, Compensation, Governance, Technology, and Finance, each with defined oversight roles.
Latest events from Albertsons Companies
- Key votes include director elections, auditor ratification, and governance amendments.ACI
Proxy filing22 Jun 2026 - Proxy covers director elections, compensation, governance reforms, and ESG priorities.ACI
Proxy filing8 Jun 2026 - Q4 net loss from opioid settlement; digital sales up 16% and dividend raised 13%.ACI
Q4 202614 Apr 2026 - Q3 delivered solid sales and digital growth, but faces post-merger litigation and margin pressure.ACI
Q3 202510 Jan 2026 - Identical sales and digital growth lifted revenue, but margins narrowed amid ongoing investments.ACI
Q1 20269 Jan 2026 - Q3 2025 saw 2.4% identical sales growth, strong digital gains, and major capital actions.ACI
Q3 20267 Jan 2026 - Q2 2025 saw 2.0% revenue growth, higher net income, and a $750M share buyback announcement.ACI
Q2 20267 Jan 2026 - Q4 delivered strong digital and pharmacy growth, but margin pressure tempers 2025 optimism.ACI
Q4 202519 Dec 2025 - Board recommends against all shareholder proposals; focus remains on digital growth and ESG impact.ACI
Proxy Filing1 Dec 2025